Patient Guide: (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 25 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05907954
Status: 🟢 Enrolling Now
Condition: Uveal Melanoma
Phase: PHASE2

Where You Can Participate

This study is available at 25 locations across the country.

Top locations include:
  • • Scottsdale, Arizona
  • • La Jolla, California
  • • Los Angeles, California
  • • And 22 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma - Join Clinical Trial NCTNCT05907954

How to Join This Clinical Trial - NCTNCT05907954

Learn how to participate in this PHASE2 trial studying an investigational therapy for Uveal Melanoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Uveal Melanoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Uveal Melanoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05907954 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 25 locations. Find a study site near you:

Clinical Research Site

Scottsdale, Arizona 85258 - United States

Status: RECRUITING

Clinical Research Site

La Jolla, California 92093 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90024 - United States

Status: RECRUITING

Clinical Research Site

Palo Alto, California 94305 - United States

Status: RECRUITING

Clinical Research Site

Denver, Colorado 80218 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33146 - United States

Status: RECRUITING

Clinical Research Site

Grand Rapids, Michigan 49546 - United States

Status: RECRUITING

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: RECRUITING

Clinical Research Site

Manhasset, New York 11030 - United States

Status: RECRUITING

Clinical Research Site

Durham, North Carolina 27710 - United States

Status: WITHDRAWN

And 15 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Uveal Melanoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships